Scilex Holding Company Interest Income Deposit With Financial Institution Increase Decrease
Scilex Holding Company (SCLX) reported Interest Income Deposit With Financial Institution Increase Decrease of $696.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-04.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease · last filed 2022-11-04
- Scilex Holding Company interest income deposit with financial institution increase decrease for the quarter ending 2022-09-30 was $459.00K, a 22850.00% increase year-over-year.
- Scilex Holding Company interest income deposit with financial institution increase decrease for the quarter ending 2022-06-30 was $204.00K, a 2814.29% increase year-over-year.
- Scilex Holding Company interest income deposit with financial institution increase decrease for the quarter ending 2022-03-31 was $33.00K, a 73.68% increase year-over-year.
- Scilex Holding Company interest income deposit with financial institution increase decrease for the quarter ending 2021-12-31 was $3.00K.
- Scilex Holding Company interest income deposit with financial institution increase decrease for fiscal 2021 was $31.00K.
| Period end | Interest Income Deposit With Financial Institution Increase Decrease 3 month | Interest Income Deposit With Financial Institution Increase Decrease 6 month | Interest Income Deposit With Financial Institution Increase Decrease 9 month | Interest Income Deposit With Financial Institution Increase Decrease 12 month |
|---|---|---|---|---|
| 2022-09-30 | $459.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $663.00K derived: sum of 2 quarters · filed 2022-11-04 | $696.00K 10-Q · filed 2022-11-04 | $699.00K derived: sum of 4 quarters · filed 2022-11-04 |
| 2022-06-30 | $204.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $237.00K 10-Q · filed 2022-08-12 | $240.00K derived: sum of 3 quarters · filed 2022-08-12 | $242.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2022-03-31 | $33.00K 10-Q · filed 2022-05-16 | $36.00K derived: sum of 2 quarters · filed 2022-05-16 | $38.00K derived: sum of 3 quarters · filed 2022-05-16 | $45.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2021-12-31 | $3.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-02-24 | $5.00K derived: sum of 2 quarters · filed 2022-02-24 | $12.00K derived: sum of 3 quarters · filed 2022-02-24 | $31.00K 10-K · filed 2022-02-24 |
| 2021-09-30 | $2.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2021-12-08 | $9.00K derived: sum of 2 quarters · filed 2021-12-08 | $28.00K 10-Q/A · filed 2021-12-08 | |
| 2021-06-30 | $7.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2021-08-24 | $26.00K 10-Q/A · filed 2021-08-24 | ||
| 2021-03-31 | $19.00K 10-Q · filed 2021-07-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |